Gina Johnson

Gina Johnson joins as Genprex’s Senior Manager, QC, Stability & Product Lifecycle Management. Ms. Johnson’s role focuses on establishing a robust stability program for all the excipients and drug products at Genprex in addition to implementation of software and definition of CQAs and testing strategies for the next phases of clinical trials. She is responsible for managing and reviewing final drug release and stability data to support release and stability protocols of raw materials and final drug products. She ensures that all procedures and processes meet internal quality standard as well as external regulations specific to pre-clinical, clinical and commercial manufacturing.

Ms. Johnson has more than five years of combined experience working in Quality Control in the pharmaceutical and biotechnology industries and in the cell and gene therapy field.

Prior to joining Genprex, Gina was a Senior QC Analyst at Immatics, where she established the microbiology department and was responsible for developing microbiological assays and managing testing by compendial method. Prior to that, she worked at Lonza in the QC department where she was responsible for release testing, stability assays, assay qualifications and validation studies.

Ms. Johnson holds a masters degree in molecular biotechnology from the University of Houston and a BS in biology from Houston Baptist University.